January 26, 2012. *NEWTOWN, PA* – BioClinica®, Inc., (NASDAQ: BIOC), a leading global provider of clinical trial management solutions, announced that Mark L. Weinstein, President and Chief Executive Officer will be presenting at the UBS 22nd Annual Global Healthcare Services Conference in New York City on Tuesday, February 7, 2012 at 4:00 p.m. EST.
*– Leading European CRO Chooses 'Flexible and Affordable' Clinical Trial Management (CTMS) Technology –*
– Experts Will Present Perspectives on Regulatory Guidances and Driving Clinical Trial Efficiency –
*– Conference Call to be Held at 11:00 a.m. EST –*
December 17, 2010. *NEWTOWN, PA* – BioClinica®, Inc., (NASDAQ: BIOC), a global provider of clinical trial management services[http://www.bioclinica.com/eClinical/], announced that its Board of Directors has authorized a share repurchase program of up to $2.0 million of the Company's common stock over the next 18 months.
eClinical 2011: Remedies for the Clinical Trials Machine
Bucks software firm manages drug-trial data. And it's hiring.
*– Oncology Pioneer Leverages BioClinica EDC Technology to Accelerate Development of New Therapies –*
*– Conference Call Today at 11:00 A.M. EDT –*
*– Clinical Trials Solution Provider Attributes 87 Percent, Four-Year Total Revenue Increase to Solid Growth Strategy and Continued Employee Commitment –*